R. M. Du Bois (London, United Kingdom), R. Baughman (Cincinnati, United States of America)
Introduction: Diagnostic criteria of extrinsic allergic alveolitios
Y. Cormier (Ste-Foy, Canada)
|  |
Functional predictors of dyspnea, 6-min walking distance and HRCT score in idiopathic interstitial pneumonia
M. Mura, A. Ferretti, M. Schiavina, A. Cavalli, H. Ghezzo, M. Zompatori, M. Fabbri, J. Milic-Emili (Bologna, Parma, Italy; Montreal, Canada)
|  |
The relationship between exercise test variables and other measures of functional impairment in fibrosing alveolitis associated with systemic sclerosis
G. Kiter, D. Cramer, R. M. Du Bois, A. U. Wells (London, United Kingdom)
| |
Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis
N. Kohno, A. Yokoyama, K. Kondo, M. Nakajima, the KL-6 Study Group (Hiroshima, Japan)
| |
Survival in idiopathic pulmonary fibrosis: results of the IFIGENIA follow up study
M. Thomeer, M. Demedts, J. Behr, R. Buhl, U. Costabel, R. Dekhuijzen, H. M. Jansen, F. Laurent, A. G. Nicholson, E. K. Verbeken, J. Verschakelen, C. D. R. Flower, B. Wallaert (Leuven, Belgium)
| |
Zileuton versus azathioprine/prednisone in idiopathic pulmonary fibrosis
K. R. Flaherty, M. Peters-Golden, W. Travis, T. Colby, B. Gross, E. Kazerooni, G. Toews, D. Dahlgren, F. J. Martinez (Ann Arbor, Washington, Scottsdale, United States Of America)
| |
Infliximab therapy in interstitial lung disease associated with rheumatoid arthritis
K. M. Antoniou, M. Mamoulaki, K. Malagari, E. G. Tzortzaki, D. Bouros, D. Boumpas, N. M. Siafakas (Heraklion, Athens, Alexandroupolis, Greece)
| |
The outcome of immune alveolar hemorrhage
S. F. Oymak, B. Tokgoz, H. Buyukoglan, H. Akgun, I. Gulmez, R. Demir, O. Oymak, C. Utas, M. Ozesmi (Kayseri, Turkey)
| |